WASHINGTON: President Donald Trump’s first week in office isn’t over yet, but already it offers signals about how his next ...

DUBAI: When the UN launched the Sustainable Development Goals in 2015, it set out a bold action plan to eliminate premature ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

Citation: Walker J, Dimcea G (2025) Assessment and management of knee pain: taking a holistic approach. Nursing Times [online], 121; 1. Authors: Jennie Walker is principal lecturer and Gruia Dimcea is ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

This self-assessment tests your knowledge after reading the following article: Walker J, Dimcea G (2025) Assessment and management of knee pain: taking a holistic approach. Nursing Times [online], 121 ...

First Pediatric Guideline on Opioid Prescribing in Primary Care Focuses on Preventing Overdose ... Researchers Seek to Improve Advanced Pain Management Using AI for Drug Discovery Oct. 4, 2024 ...

Taking good care of your body is also taking good care of your mind. While this won’t help treat anxiety chest pain, it may help you reduce your risk for anxiety and subsequent chest pain in the ...